Dataset from A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Alogliptin and Metformin Fixed Dose Combination, Alogliptin Alone, or Metformin Alone in Subjects With Type 2 Diabetes Mellitus

The purpose of this study is to evaluate the efficacy and safety of alogliptin and metformin fixed-dose combination (FDC) as compared with alogliptin alone or metformin alone on Type 2 Diabetes Mellitus (T2DM).

本研究旨在评估阿格列汀与二甲双胍固定剂量复方制剂（fixed-dose combination, FDC）相较于单用阿格列汀或单用二甲双胍，用于2型糖尿病（Type 2 Diabetes Mellitus, T2DM）治疗的有效性与安全性。